Colorectal liver metastases (CRLM), cancer that has spread from the colon or rectum to the liver, have a deadly reputation. Due to its pervasive spread, typical cancer treatments like chemotherapy and ...

Objectives This substudy investigated whether medicinal cannabis causes an elevation in alanine aminotransferase (ALT) or aspartate aminotransferase (AST) in patients with advanced malignancy and ...

Cells from cancerous tumors can spread, or metastasize, throughout the body. Researchers have long sought to understand what determines where those cells will go and thrive in order to more ...

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.

Variance in incidence seen across cancer types, but consistently increased with later stage at initial diagnosis. (HealthDay News) — Nearly one in 10 adolescent and young adult patients diagnosed with ...

A groundbreaking study published in Current Molecular Pharmacology has uncovered a novel three-lncRNA signature that could improve early diagnosis and treatment strategies for non-metastatic ...

In a population-based cohort of 15- to 39-year-olds diagnosed with cancer, the risk for metastatic recurrence varied widely by cancer type and stage, and survival after recurrence was worse than after ...

Despite decades of progress in treating primary tumors, metastasis remains the final frontier and the central challenge in oncology. At late stages of cancer progression, primary localized tumors may ...

Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered unattainable. Dr. Augusto Villanueva Rodriguez, medical director of the Liver ...

Merck & Co. and Eisai previously had high hopes for their Keytruda-Lenvima combination in a liver cancer subtype based on positive progression-free survival data, but now the combo’s promise has once ...